Correction of stopping power and LET quenching for radiophotoluminescent glass dosimetry in a therapeutic proton beam
Creators
- 1. Tokyo Metropolitan University, 7-2-10 Higashi-Ogu, Arakawa-ku, Tokyo 116-8551 (Japan)
- 2. National Institute of Radiological Sciences, 4-9-1, Anagawa, Inage-ku, Chiba 263-8555 (Japan)
- 3. Fujita Health University, 1-98 Dengakugakubo, Kutsukake-chou, Toyoake-shi, Aichi 470-1192 (Japan)
- 4. Nagoya Proton Therapy Center, Nagoya City West Medical Center 1-1-1 Hirate-cho, Kita-ku, Nagoya 462-8508 (Japan)
Description
To measure the absorbed dose to water D w in proton beams using a radiophotoluminescent glass dosimeter (RGD), a method with the correction for the change of the mass stopping power ratio (SPR) and the linear energy transfer (LET) dependence of radiophotoluminescent efficiency is proposed.
The calibration coefficient in terms of D w for RGDs (GD-302M, Asahi Techno Glass) was obtained using a 60Co γ-ray. The SPR of water to the RGD was calculated by Monte Carlo simulation, and was investigated experimentally using a 70 MeV proton beam. For clinical usage, the residual range R res was used as a quality index to determine the correction factor for the beam quality and the LET quenching effect of the RGD . The proposed method was evaluated by measuring D w at different depths in a 200 MeV proton beam.
For both non-modulated and modulated proton beams, decreases rapidly where R res is less than 4 cm. The difference in between a non-modulated and a modulated proton beam is less than 0.5% for the R res range from 0 cm to 22 cm. decreases rapidly at a LET range from 1 to 2 keV µm−1. In the evaluation experiments, D w using RGDs, showed good agreement with that obtained using an ionization chamber and the relative difference was within 3% where R res was larger than 1 cm. The uncertainty budget for in a proton beam was estimated to investigate the potential of RGD postal dosimetry in proton therapy.
These results demonstrate the feasibility of RGD dosimetry in a therapeutic proton beam and the general versatility of the proposed method. In conclusion, the proposed methodology for RGDs in proton dosimetry is applicable where R res > 1 cm and the RGD is feasible as a postal audit dosimeter for proton therapy. (paper)
Availability note (English)
Available from http://dx.doi.org/10.1088/1361-6560/aa9155Additional details
Identifiers
Publishing Information
- Journal Title
- Physics in Medicine and Biology
- Journal Volume
- 62
- Journal Issue
- 23
- Journal Page Range
- p. 8869-8881
- ISSN
- 0031-9155
- CODEN
- PHMBA7
INIS
- Country of Publication
- United Kingdom
- Country of Input or Organization
- International Atomic Energy Agency (IAEA)
- INIS RN
- 52003294
- Subject category
- S46: INSTRUMENTATION RELATED TO NUCLEAR SCIENCE AND TECHNOLOGY; S62: RADIOLOGY AND NUCLEAR MEDICINE;
- Descriptors DEI
- ABSORBED RADIATION DOSES; COBALT 60; GLASS; IONIZATION CHAMBERS; MONTE CARLO METHOD; PROTON BEAMS; PROTON DOSIMETRY; PROTONS; QUENCHING; RADIOTHERAPY; STOPPING POWER
- Descriptors DEC
- BARYONS; BEAMS; BETA DECAY RADIOISOTOPES; BETA-MINUS DECAY RADIOISOTOPES; CALCULATION METHODS; COBALT ISOTOPES; DOSES; DOSIMETRY; ELEMENTARY PARTICLES; FERMIONS; HADRONS; INTERMEDIATE MASS NUCLEI; INTERNAL CONVERSION RADIOISOTOPES; ISOMERIC TRANSITION ISOTOPES; ISOTOPES; MEASURING INSTRUMENTS; MEDICINE; MINUTES LIVING RADIOISOTOPES; NUCLEAR MEDICINE; NUCLEI; NUCLEON BEAMS; NUCLEONS; ODD-ODD NUCLEI; PARTICLE BEAMS; RADIATION DETECTORS; RADIATION DOSES; RADIOISOTOPES; RADIOLOGY; THERAPY; YEARS LIVING RADIOISOTOPES